Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia

ABSTRACTChronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world. It is characterized by a high dependency on interactions with the surrounding immune landscape, highlighting its suitability for immune-mediated therapeutic interventions. We recently revealed that the...

Full description

Bibliographic Details
Main Authors:	Iria Fernandez Botana, Giulia Pagano, Etienne Moussay, Jerome Paggetti
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	OncoImmunology
Subjects:	Cytokine IL-27 CD8+ T cells immunotherapy leukemia
Online Access:	https://www.tandfonline.com/doi/10.1080/2162402X.2023.2276490

Similar Items

Interleukin-27 in Tuberculosis: A Sheep in Wolf’s Clothing?
by: Kristina Ritter, et al.
Published: (2022-01-01)

The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
by: Susanne Gonder, et al.
Published: (2021-09-01)

Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses
by: Quentin Jouhault, et al.
Published: (2023-02-01)

The cytokine IL-27 reduces inflammation and protects photoreceptors in a mouse model of retinal degeneration
by: Andrea Nortey, et al.
Published: (2022-09-01)

A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications
by: Janelle Wesleyn Salameh, et al.
Published: (2022-02-01)

Investigation of the role of interleukin 27 in the immune regulation of Treg and Th17 cells in neurosyphilis patients
by: Wei Zhao, et al.
Published: (2023-10-01)

Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
by: Nahla Anber, et al.
Published: (2020-02-01)

Interleukin-27 impairs BCG antigen clearance and T cell stimulatory potential by neonatal dendritic cells
by: Shelby D. Bradford, et al.
Published: (2023-01-01)

CD27+ microparticle interactions and immunoregulation of CD4+ T lymphocytes
by: Léonie Cagnet, et al.
Published: (2023-03-01)

Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance
by: Lin Zhang, et al.
Published: (2019-01-01)

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
by: M. N Khorobrykh, et al.
Published: (2014-07-01)

Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia
by: Laura Patrussi, et al.
Published: (2021-12-01)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
by: Karima Kacem, et al.
Published: (2019-11-01)

Natural killer cells and bone marrow mesenchymal stem cells: A dangerous liaison in multiple myeloma
by: Iria Fernandez Botana, et al.
Published: (2022-09-01)

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy
by: Martina Seiffert, et al.
Published: (2022-02-01)

Study the mRNA level of IL-27/IL-27R pathway molecules in kidney transplant rejection
by: Aftab Karimi, et al.
Published: (2023-12-01)

Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model
by: Daniel P. Brice, et al.
Published: (2022-03-01)

Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses
by: Stephan Wilmes, et al.
Published: (2021-04-01)

Evaluation Of the Immunopatho Role Of Interleukins IL17, IL21,and CD4+,CD8+ T cells In Patients With Type 1 Diabetes In The City of Baquba
by: Ban Shabib Mohsen, et al.
Published: (2018-08-01)

Evaluation Of the Immunopatho Role Of Interleukins IL17, IL21,and CD4+,CD8+ T cells In Patients With Type 1 Diabetes In The City of Baquba
by: Ban Shabib Mohsen, et al.
Published: (2018-08-01)

IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells
by: Maria Lourdes Macalinao, et al.
Published: (2023-12-01)

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013-01-01)

SECRETION OF IL-12, IL-27 BY MONONUCLEAR LEUKOCYTES AND EXPRESSION OF THEIR RECEPTORS ON T-LYMPHOCYTES IN CONDITIONS OF DIRECTED CELL INDUCTION IN VITRO IN PULMONARY TUBERCULOSIS
by: I. E. Esimova, et al.
Published: (2014-08-01)

The Role of gp130 Cytokines in Tuberculosis
by: Kristina Ritter, et al.
Published: (2020-12-01)

Interleukin-27 Early Impacts Leishmania infantum Infection in Mice and Correlates with Active Visceral Disease in Humans
by: Begoña Pérez-Cabezas, et al.
Published: (2016-11-01)

The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients
by: Serap Yalçın, et al.
Published: (2015-12-01)

BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia
by: Christian Sordo-Bahamonde, et al.
Published: (2021-04-01)

The role of interleukin-27 in atherosclerotic cardiovascular diseases: A review
by: Amina M. Alieva, et al.
Published: (2023-10-01)

Correlation of regulatory T cells in chronic lymphocytic leukemia characterized by high-affinity CD25 expression with serum IL-2 values, IGVH mutational status, Rai stage, and therapeutic lines
by: Georgiana Ene, et al.
Published: (2020-09-01)

Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
by: David E. Spaner, et al.
Published: (2023-04-01)

IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium
by: Caroline Andrews, et al.
Published: (2023-04-01)

Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases
by: Andrea N Nortey, et al.
Published: (2022-01-01)

Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia
by: Kunlin Pei, et al.
Published: (2023-04-01)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
by: Vanessa Klapp, et al.
Published: (2023-12-01)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
by: Marco Herling, et al.
Published: (2022-09-01)

Editorial: IL-27 in health and disease
by: Tomozumi Imamichi, et al.
Published: (2023-03-01)

Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia
by: Agnieszka Goral, et al.
Published: (2023-10-01)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
by: Hongnga T. Le, et al.
Published: (2020-02-01)

Role, involvement and potential of interleukin-27 as an immunotherapeutic target in murine malaria
by: Fazalul Rahiman, Siti Sarah
Published: (2012)

Hematological Malignancy-Derived Small Extracellular Vesicles and Tumor Microenvironment: The Art of Turning Foes into Friends
by: Ernesto Gargiulo, et al.
Published: (2019-05-01)